Annual Report 2019

FINANCIAL HIGHLIGHTS 5 The United Laboratories International Holdings Limited Annual Report 2019 2019 2018 Increase (decrease) RMB’000 RMB’000 % Revenue 8,392,600 7,510,586 11.7% EBITDA 1,798,222 1,788,400 0.5% Profit before taxation 841,652 793,879 6.0% Profit for the year attributable to owners of the Company 641,764 682,928 (6.0%) Earnings per share Basic RMB39.14 cents RMB41.80 cents (6.4%) Diluted RMB39.14 cents RMB32.27 cents 21.3% (272.4) 81.8 682.9 89.9 2015 2016 2017 2015 2016 2017 1,125.5 2018 1,788.4 1,145.8 813.4 2019 1,798.2 2015 2016 2017 2018 5.0 2015 2016 2017 41.8 2018 5.5 (16.7) 39.1 2019 2018 0 100 200 300 -300 -200 -100 400 500 600 700 800 50 40 30 20 10 0 -10 -20 641.8 2019 2,000 1,500 1,000 500 0 10,000 8,000 6,000 4,000 2,000 0 2019 1,473.5 2,853.4 2,499.7 1,233.6 3,389.7 2,887.3 1,369.3 1,235.1 2,666.4 2,234.3 6,270.0 6,077.9 6,826.6 7,510.6 8,392.6 2,470.5 2,372.3 1,280.4 3,593.1 3,519.1 REVENUE (RMB million) BASIC EARNINGS (LOSS) PER SHARE (RMB cents) PROFIT (LOSS) FORTHEYEAR ATTRIBUTABLE TO OWNERS OFTHE COMPANY (RMB million) EBITDA (RMB million) Intermediate products Bulk medicine Finished products